Ferumoxytol Patent Expiration

Ferumoxytol is Used for treating iron deficiency in patients. It was first introduced by Azurity Pharmaceuticals Inc in its drug Feraheme on Jun 30, 2009. Another drug containing Ferumoxytol is Ferabright. 2 different companies have introduced drugs containing Ferumoxytol.


Ferumoxytol Patents

Given below is the list of patents protecting Ferumoxytol, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Feraheme US6599498 Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives Mar 08, 2020

(Expired)

Azurity
Feraheme US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof Mar 08, 2020

(Expired)

Azurity
Feraheme US7871597 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Azurity
Feraheme US8501158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Azurity
Feraheme US8591864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Azurity
Feraheme US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Azurity



Ferumoxytol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Clinical Trials

Recent Clinical Trials on Ferumoxytol:

Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging National Institute of Neurological Disorders and Stroke (NINDS) NA COMPLETED
(Sep 16, 2026)
PHASE1
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System OHSU Knight Cancer Institute NA RECRUITING
(Sep 1, 2026)
PHASE2
Feasibility of FMISO in Brain Tumors OHSU Knight Cancer Institute NA RECRUITING
(Sep 1, 2026)
PHASE2
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer Colin D. Weekes, M.D., PhD NA ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE2
Calculating Wall Shear Stress in Infant Pulmonary Veins Children's Hospital of Philadelphia NA RECRUITING
(Aug 1, 2026)
PHASE1
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma Bryan Allen NA ACTIVE NOT RECRUITING
(Jun 1, 2026)
PHASE1
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants University of Washington NA RECRUITING
(May 1, 2026)
PHASE2
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy University of Alberta NA RECRUITING
(May 1, 2026)
PHASE2
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects AMAG Pharmaceuticals, Inc. NA RECRUITING
(Apr 1, 2026)
PHASE3


Ferumoxytol Generic API Manufacturers

Only one generic application has been filed for Ferumoxytol.

Given below is the list of companies who have filed for Ferumoxytol generic, along with the locations of their manufacturing plants worldwide.